The frequency of GSTT1 null genotype in Turkish population and lung cancer risk

Indian Journal of Human Genetics

Volumn 11, Issue 2, 2005, Pages 89-93

  Demir, A ^a,c   Altin, S ^a   Demir, I ^a   Koksal, V ^b   Cetincelik, U ^b   Dincer, S I ^a  

^a Yedikule Teaching Hospital   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Genetic polymorphism; GSTT1 and molecular epidemiology; Lung cancer

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

EID: 32444439915     PISSN: 09716866     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-6866.16808     Document Type: Review

References (35)

1. Parkinm DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Ferlay J, Bray F, Pisani P, Parkin DM. Cancer Incidence, Mortality and Prevalance Worlwide (1.0), CancerBase no.5. IARC, Lyon, France. 2001 GLOBOCAN 2000
3. Perera FP. Molecular epidemiology of environmental carcinogenesis. Recent Results Cancer Res 1998;154:39-46.
4. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility. Gene 1995;159:113-21.
5. Strogn LC, Amos CI. Inherited susceptibility. In Schottenfeld D, Searle JG and Fraumeni JF (Eds). Cancer Epidemiology and Prevention. Oxford University Press: NewYork; 1996. p. 559-82.
6. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 2003;32:60-3.
7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30;445-600.
8. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999;148;231-49.
9. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
10. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Gluthione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colerectal cancers. Carcinogenesis 1996;17:881-4
11. Jourenkova N, Reinikanen M, Bouchardy C, Husgafvel-Pursiainen K, Dayer P, Benhamou S, et al. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics 1997;7:515-8.
12. Teixeira JP, Gaspar J, Martinho G, Silva S, Rodrigues S, Mayan O, et al. Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in genes GSTP1, GSTM1, GSTT1 and CYP1A1. Mutat Res. 2002;517:147-55.
13. Wang J, Deng Y, Cheng J, Ding J, Tokudome S.GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
14. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18;1285-9.
15. Kihara M, Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 1999;137:53-60.
16. Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S, et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 1998;8:495-502.
17. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological Consequences. Pharmacology 2000;61:154-66.
18. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998;58:4858-63.
19. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998;77:516-21.
20. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001;11:757-64.
21. Salagovic J, Kalina I, Stubna J, Habalova V, Hrivnak M, Valansky L, et al. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 1998;45:312-7.
22. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Fuentes M, Ramon JM, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 1997;18:1529-33.
23. Sun GF, Shimojo N, Pi JB, Lee S, Kumagai Y. Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population. Cancer Lett 1997;113:169-72.
24. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 2002;11:730-8.
25. Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control 1997;8:554-9.
26. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al. Ethnic difference in the prevalence of the homozygous deleted genotype of glutathione S-transferase. Carcinogenesis 1995;16:1243-5
27. Lee KA, Kim SH, Woo HY, Hong YJ, Cho HC. Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia. Blood 2001;98:3483-5.
28. Tamer L, Calikoglu M, Ates NA, Yildirim H, Ercan B, Saritas E, et al. Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 2004;9:493-8.
29. Özbek U, Aydýn M, Hatýrnaz A, et al. Metabolising Enzyme Polymorphisms (GSTM1, GSTT1, CYP1A1, CYP2D6) and Their Association as a Potential Susceptibility to Pediatric ALL. American Society of Hematology 43rd Annual Meeting and Exposition: Orlando, FL; 2001.
30. Tamer L, Ercan B, Camsari A, Yildirim H, Cicek D, Sucu N, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 2004;99:223-9.
31. Ada AO, Suzen SH, Iscan M. Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 2004;15:311-5.
32. Oke B, Akbas F, Aydin M, Berkkan H. GSTT1 null genotype frequency in a Turkish population. Arch Toxicol 1998;72:454-5
33. Toruner GA, Akyerli C, Ucar A, Aki T, Atsu N, Ozen H, et al. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 2001;75:459-64.
34. Tursen U, Tamer L, Eskandari G, Kaya TI, Ates NA, Ikizoglu G, et al. Glutathione S-transferase polymorphisms in patients with Behcet's disease. Arch Dermatol Res 2004;296:185-7.
35. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.